About NanoView Biosciences
NanoView Biosciences is a company based in Boston (United States) founded in 2015 was acquired by Unchained Labs in May 2022.. NanoView Biosciences has raised $16 million across 11 funding rounds from investors including Unchained Labs, National Science Foundation and Sands Capital Ventures. The company has 24 employees as of December 31, 2022. NanoView Biosciences offers products and services including Aunty, Stunner, Leprechaun, Honeybun, and Unagi. NanoView Biosciences operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Boston, United States
- Employees 24 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanoview Biosciences Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16 M (USD)
in 11 rounds
-
Latest Funding Round
$2.5 M (USD), Debt – Conventional
Mar 01, 2022
-
Investors
Unchained Labs
& 6 more
-
Employee Count
24
as on Dec 31, 2022
-
Acquired by
Unchained Labs
(May 04, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoView Biosciences
NanoView Biosciences offers a comprehensive portfolio of products and services, including Aunty, Stunner, Leprechaun, Honeybun, and Unagi. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-throughput system for protein stability characterization.
Instrument for protein and nucleic acid quantification and sizing.
System for lentivirus and exosome structure analysis.
Rapid viscometer for biological sample measurements.
Hands-free system for buffer exchange in samples.
All-in-one platform for biologics stability testing.
Unlock access to complete
Unlock access to complete
Funding Insights of NanoView Biosciences
NanoView Biosciences has successfully raised a total of $16M across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.5 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Debt – Conventional — $2.5M
-
First Round
First Round
(01 Jan 2015)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Debt – Conventional - NanoView Biosciences | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - NanoView Biosciences | Valuation |
investors |
|
| Dec, 2020 | Amount | Series B - NanoView Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NanoView Biosciences
NanoView Biosciences has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Unchained Labs, National Science Foundation and Sands Capital Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NanoView Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NanoView Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanoview Biosciences Comparisons
Competitors of NanoView Biosciences
NanoView Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanoview Biosciences
Frequently Asked Questions about NanoView Biosciences
When was NanoView Biosciences founded?
NanoView Biosciences was founded in 2015.
Where is NanoView Biosciences located?
NanoView Biosciences is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is NanoView Biosciences a funded company?
NanoView Biosciences is a funded company, having raised a total of $16M across 11 funding rounds to date. The company's 1st funding round was a Series B of $6M, raised on Jan 01, 2015.
How many employees does NanoView Biosciences have?
As of Dec 31, 2022, the latest employee count at NanoView Biosciences is 24.
What does NanoView Biosciences do?
NanoView Biosciences was founded in 2015 in Boston, United States, within the nanotechnology and molecular diagnostics sector. A platform utilizing Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS) is offered for biomolecule detection at single-target resolution. ExoView technology enables characterization on affinity microarray platforms from samples including blood, serum, plasma, and urine. Development of tests for viral hemorrhagic fevers such as Ebola, Lassa, and Marburg is underway.
Who are the top competitors of NanoView Biosciences?
NanoView Biosciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does NanoView Biosciences offer?
NanoView Biosciences offers Aunty, Stunner, Leprechaun, Honeybun, and 2 more products and services.
Who are NanoView Biosciences's investors?
NanoView Biosciences has 7 investors. Key investors include Unchained Labs, National Science Foundation, Sands Capital Ventures, PBM Capital, and Northpond Ventures.